coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Chorley And South Ribble Network PCN, Chorley · Health Inequalities Profile

    PCN U10791 · NHS Lancashire and South Cumbria Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    23,384

    Registered population

    62.7% aged 18–64

    13.8%

    Aged 65+

    ICB 20.0% · England 17.9%

    3.0%

    Ethnic minority (non-White)

    1.7% Asian · England 9.6%

    4.9%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~959

    Core20 residents (est.)

    Resident basis; registered basis ~1,093 · see page 3

    2,993

    Hypertension register

    +5.88% in 3 yrs · England +5.60%

    217

    SMI register

    15.9% of Chorley's

    303

    COPD register

    Reviews +10.72% in 3 yrs

    Forecast to 2030

    3,622

    Hypertension patients, 2030

    +629 on today

    65.2%

    QRISK ≥20% on statins, 2030

    +4.34pp over 3 yrs

    3.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -6.8 pp
    SMI physical health checks fell against England.

    SMI BMI recording fell 6.8 pp over 2023 to 2025 to 73.4% (England +5.1 pp to 82.1%), which may reflect unverified recall gaps.

    55.4%
    High-risk lipid and statin therapy lags comparators.

    Lipid therapy for QRISK ≥ 20% is 55.4% (England 63.6%) and statins in non-CVD diabetes reach 62.2% (England 73.2%), suggesting unverified recall gaps.

    90.1%
    Respiratory reviews and BP monitoring outperform England.

    Annual COPD reviews reach 90.1% (England 76.4%, Chorley 82.4%) and recent hypertension BP readings reach 91.7% (England 90.0%), showing strong registered-patient review delivery.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger population with 13.8% aged 65+ contrasts with 24 catchment care homes

    Across 23,384 registered patients, 13.8% are aged 65+ (3,223 patients), well below Chorley (20.2%), the ICB (20.0%) and England (17.9%), while 23.5% are aged 0-17 (Chorley 19.3%, ICB 19.6%, England 19.6%). Buckshaw Village Health Centre is younger (28.1% aged 0-17; 8.3% aged 65+) than Adlington Medical Centre (18.3% aged 0-17; 20.0% aged 65+). Residential Census data indicates 97.0% White ethnicity (Chorley 95.6%, ICB 87.8%, England 81.1%) and 3.0% ethnic minority residents. Projected list growth to 2030 is 4.0% (Chorley 2.4%, ICB 1.7%, England 2.3%), though the projection method is unverified.

    Age profile

    0–1723.5%
    18–6462.7%
    65+13.8%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White97.0%
    Asian1.7%
    Mixed0.8%
    Black0.3%
    Other0.1%

    Older people · falls rows are Chorley local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Chorley LA)1,6352,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.4%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.4%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Chorley LA)7431,0219552024/25
    Falls deaths, all ages, per 100,000 (Chorley LA)10.418.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Overall Core20 share is 4.9%, with need concentrated at Adlington Medical Centre

    Average IMD decile for CHORLEY AND SOUTH RIBBLE NETWORK PCN is 7.0, compared to England at 5.5 decile, Chorley at 6.5 decile, and NHS Lancashire and South Cumbria Integrated Care Board at 5.0 decile. The Core20 cohort is 4.9%, below Chorley (11.4 percent), NHS Lancashire and South Cumbria Integrated Care Board (30.6 percent), and England (21.0 percent). Modelled weighted practice Core20 share is 4.7%. Prioritising Adlington Medical Centre may offer greater operational impact, which is consistent with its higher captured Core20 share and estimated patient volume; local service uptake audits.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Adlington6.9% · 757 patients
    Buckshaw Village2.7% · 336 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    217

    SMI register

    0.94% recorded prevalence

    108

    Learning disability register

    0.47% recorded prevalence

    24

    Care homes, 769 beds

    In the PCN catchment

    9.3%

    Provide unpaid care

    Chorley, Census 2021

    Learning disability prevalence is 0.5% (108 patients), trailing Chorley (0.6%), the ICB (0.6%) and England (0.6%). The mental illness register records 217 patients (0.9% vs Chorley 1.1%, ICB 1.2%, England 1.0%), alongside 24 catchment care homes (769 beds, occupancy unconfirmed). Crude prevalence does not establish under-detection or unmet need, requiring list validation.

    Severe mental illness: physical health checks

    Across 217 SMI patients, recorded BMI is 73.4% (England 82.1%) and BP checks reach 75.3% (England 83.4%). Over 2023 to 2025, BMI checks fell 6.8 pp (England +5.1 pp), which could reflect unverified physical health monitoring gaps.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    2,993

    Hypertension register

    +5.88%

    Register growth, 3 yrs

    Chorley +6.44% · England +5.60%

    +9.70pp

    BP control, under 80

    ≤140/90 · +2.56pp aged 80+

    +629

    More patients by 2030

    Forecast 3,622 (14.49%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 12.9% (2,993 patients), below Chorley (17.5%), the ICB (17.2%) and England (15.2%), ranging from 9.1% at Buckshaw Village Health Centre to 17.1% at Adlington Medical Centre. Lower recorded prevalence may reflect a younger population (13.8% aged 65+ versus 20.2% in Chorley), so the unadjusted register gap of +568 to +1,092 patients is an upper bound. Recent blood pressure readings reach 91.7% (England 90.0%), and treatment to target reached 68.7% (England 70.3%), rising +9.3 pp over 2023 to 2025 (England +2.5 pp). High blood pressure check coverage alongside below-average crude prevalence suggests case-finding audits in younger cohorts could test whether register gaps reflect age structure.

    Lipids and statins

    Lipid therapy trails England for QRISK ≥ 20% (55.4% vs 63.6%), diabetes without CVD (62.2% vs 73.2%), and CKD (63.2% vs 70.3%), with diabetes and CVD at 80.4% (England 84.4%). Lower coverage across cohorts could reflect unverified review or shared-care recording gaps, testable by targeted clinical audit.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202627,186£1.90£1.64£1.86£51,653
    Cardiovascular (all), 202546,625£3.75£3.38£3.33£174,844

    In 2026, the PCN prescribed 27,186 lipid-regulating items at £1.90 per item (England £1.86, Chorley £1.79, ICB £1.64), spending £1,087 more than at England's unit cost and £7,068 more than at the ICB's unit cost. Prescribing review could test whether product selection explains unit-cost differences against local benchmarks.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +5.11%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +7.09%

    Asthma prevalence, PCN 3-yr % change

    COPD review coverage reaches 90.1% (England 76.4%, Chorley 82.4%), with registers expanding +14.3% over 2023 to 2025 across 303 patients. Asthma annual reviews achieve 74.3% (England 65.7%), though about 380 of 1,496 registered asthma patients lacked a recorded review. Second-hand smoking status was recorded for 96.3% of youth asthma patients (England 78.8%). Asthma prescribing for ages 5-19 is 930 per 1,000 (England 1,488), with Buckshaw Village Health Centre at 563 per 1,000 against 1,536 at Adlington Medical Centre, which could reflect unverified variations in paediatric management.

    Cancer register and children's immunisation

    Cancer register prevalence is 3.2% (748 patients), below England (3.8%) and Chorley (4.5%). In Q1 2025/26, 6-in-1 uptake reached 100.0% at 12 months, but age-5 boosters drop off: MMR2 is 88.4% (below the 95.0% target by 6.6 pp) and the 4-in-1 booster is 84.1% (below target by 10.9 pp). Across the PCN, MMR coverage drops 7.3 pp between dose one and dose two at age 5.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months100.0%

    England 91.0%

    6-in-1 complete primary course at 24 months93.1%

    England 92.2%

    MMR dose 1 at 24 months93.1%

    England 88.3%

    MMR dose 2 at age 588.4%

    England 82.8%

    4-in-1 pre-school booster at age 584.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022, 52.4% of staged cancers in NHS Lancashire and South Cumbria ICB (4,642 of 8,863) were diagnosed at stage 1 or 2, trailing England (55.3%) and 22.6 pp below the 75.0% ambition by 2028. Staging completeness was 74.6% (8,863 of 11,883 cancers), and early-stage share fell 1.2 pp since 2013, leaving an annual scale gap of about 2,010 cases. These system figures do not measure PCN performance. Locally, cervical screening is 75.1% (England 66.8%) but fell 1.8% over 2023 to 2025 (England -1.0%), while breast screening is 67.6% (Chorley 72.7%, England 69.9%). Sustaining screening uptake is the PCN's chief lever to support system early detection.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, provider data shows Lancashire Teaching Hospitals NHS Foundation Trust met the 75.0% 28-day faster diagnosis standard at 82.9% (Wrightington, Wigan and Leigh 82.8%, East Lancashire 81.5%, England 79.3%, ICB 78.4%). However, its 62-day referral to treatment rate was 75.0%, below the 85.0% standard by 10.0 pp (Wrightington, Wigan and Leigh 76.8%, ICB 73.6%, East Lancashire 73.2%, England 71.2%). Diagnostic 6+ week waits reached 26.7% at Lancashire Teaching Hospitals (England 23.1%, Wrightington, Wigan and Leigh 14.4%, East Lancashire 3.2%), led by non-obstetric ultrasound at 28.2% and audiology at 83.0%.

    Pathways within standard (%)LancashireWrightington, Wigan and LeighEast LancashireLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)82.9082.8081.5078.3979.32
    31-day treatment (96%)89.4389.0498.1193.6292.50
    62-day referral to treatment (85%)75.0476.7873.1673.6271.16
    Diagnostic waits over 6 weeks (%)LancashireWrightington, Wigan and LeighEast LancashireEngland
    MRI2.410.490.4321.40
    CT14.977.780.159.92
    Echocardiography13.8524.370.0028.48
    Colonoscopy0.006.100.9530.83
    Gastroscopy0.0012.541.1629.02
    All 15 DM01 tests26.6514.363.2523.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In provisional June 2026 experimental data, Lancashire upper-tier authority recorded 293,090 community care activities, 126,445 care contacts, 47,320 patients with a contact, and 20,415 referrals, with adults aged 65+ accounting for 56.9% of contacts. Across NHS Lancashire and South Cumbria Integrated Care Board, activity reached 533,345 care activities across 65,335 patients. These figures cover submitting providers only and do not represent unique PCN patients.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Good practice experience spans 71.5% to 74.8% despite wider deprivation differences

    In 2025/26, QOF overall achievement reached 98.3% at Adlington Medical Centre and 98.5% at Buckshaw Village Health Centre, exceeding the England average of 92.5%. Both practices attained 100.0% in vaccination and immunisation points (England 55.2%), while overall personalised care adjustment rates were 6.6% at Adlington Medical Centre and 5.9% at Buckshaw Village Health Centre (England 10.0%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Buckshaw Village802.754.7%76.4%74.8%
    Adlington986.951.7%67.7%71.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNChorleyAssetPCNChorley
    Care homes (catchment)24 (769 beds)n/aSchools (catchment)58n/a
    Children's centres58Places of worship4675
    Libraries24Primary schools (LA maintained)2539
    Primary academies35Special schoolsn/a2

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    SMI physical health check recall

    Across 217 SMI patients (0.9% prevalence), BMI recording is 73.4% (England 82.1%, Chorley 80.6%), falling 6.8 pp over 2023 to 2025 (England +5.1 pp); BP checks are 75.3% (England 83.4%), falling 4.2 pp. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 2

    Pharmacist-led lipid therapy review

    Lipid therapy for QRISK ≥ 20% is 55.4% (England 63.6%, ICB 61.4%, Chorley 58.6%); statin treatment is 62.2% in non-CVD diabetes (England 73.2%) and 63.2% in CKD (England 70.3%). Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Option 3

    Learning disability register validation

    Learning disability QOF prevalence is 0.5% (108 patients across 23,384 registered), below England, the ICB and Chorley (all 0.6%), after falling 23.2% over 2023 to 2025 (England +5.4%). For discussion: audit learning disability diagnostic codes against previous register cohorts and local authority social-care records where information-sharing agreements permit. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Demographic resource alignment (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check audit (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Age-stratified hypertension audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Primary care access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · SMI physical health check recall (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Option 2 · Pharmacist-led lipid therapy review (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · Patients with diabetes (40+ yrs no history of CVD) treated with a statin (denominator incl. PCAs) · CKD patients treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15